Drug Launch Tracker

Brand-Name Drugs Starting With K

The month or window each one is expected to get its first, lower-cost generic. Each drug opens its own launch page with the patents, approvals and prices behind its month.

Dr. Brian Staiger, PharmD, BCPS

This list is aggregated from FDA records, court filings and company announcements. Coded and designed by

Updated October 9, 2026 How we build our data

K

  • Kalydeco Ivacaftor Jan to Jun 2028
  • Katerzia Amlodipine Benzoate 2029 to 2030
  • Kengreal Cangrelor 2033 to 2035
  • Kerendia Finerenone August 2033
  • Khapzory Levoleucovorin March 2039
  • Khindivi Hydrocortisone February 2043
  • Kimyrsa Oritavancin Diphosphate August 2029
  • Kisqali Ribociclib Succinate Jul to Sep 2031
  • Kisqali Femara Co-Pack Letrozole and Ribociclib Jul to Sep 2031
  • Klisyri Tirbanibulin 2035 to 2036
  • Kloxxado Naloxone Hydrochloride 2033 to 2034
  • Komzifti Ziftomenib November 2039
  • Korsuva Difelikefalin Acetate Jul to Dec 2032
  • Koselugo Selumetinib Sulfate September 2028
  • Kovanaze Oxymetazoline Hydrochloride and Tetracaine Hydrochloride April 2030
  • Krazati Adagrasib May 2037
  • Kybella Deoxycholic Acid 2027 to 2028
  • Kygevvi Doxecitine and Doxribtimine July 2043
  • Kyleena Levonorgestrel September 2029
  • Kynamro Mipomersen Sodium January 2027
  • Kynmobi Apomorphine Hydrochloride April 2036
  • Kyprolis Carfilzomib Sometime in 2027
  • Kyzatrex Testosterone Undecanoate October 2041

See every expected first generic month by month on Generic Launches. Not seeing yours? Ask a pharmacist and we will look it up.